- Cool Tool – ClinEss® – A tissue preservation and transportation medium provides protection of cells and allows for tissue to be stabilized without fixationPosted 13 mins ago
- Video Tutorial – The Impact of Sparging on Cell Culture in BioreactorsPosted 11 hours ago
- Non-Invasive Stem Cell Characterization and Predicting Differentiation using Luminex AssaysPosted 2 days ago
- CRISPR Technology Where it Stands and What the Future HoldsPosted 1 week ago
- Ask the Expert – Using Luminex Technology to Non-Invasively Monitor Stem Cell DifferentiationPosted 1 week ago
- Controlling Cell Culture pH in BioreactorsPosted 2 weeks ago
- The Impact of Aeration on Cell Culture OptimizationPosted 4 weeks ago
- Cool Tool – Novel universal titer boost and enhancer improves CHO cell protein production in small bioreactorsPosted 1 month ago
- The Dish’s Weekly Biotechnology News Wrap Up – September 16, 2016Posted 1 month ago
- Utilizing UVC LEDs in Biotech and Pharma – Paving the way to better instrument design and better manufacturing methodsPosted 1 month ago
The Dish’s Weekly News Wrap Up – April 27, 2012
This is a new feature where we will highlight some of the week’s top biotechnology stories.
US biopharmaceutical companies are developing nearly 300 vaccines for the prevention and treatment of a wide variety of diseases, according to new industry data.
Stay tuned for an upcoming vaccine production series on The Dish
A $30 million effort from California’s stem cell research funding agency will dole out awards to help biotech or pharmaceutical companies or venture capital firms take research into early clinical trials.
If you like this story, please see our stem cell blog titled “Exciting Treatment Possibilities With Stem Cells What is the Best Cell Culture Method”
Drug companies are in such need of the latest experimental therapies to replace medicines losing patent protection that even a 68 percent takeover premium for Human Genome Sciences Inc. isn’t enough.
If you like this story, please see our blog titled “CHO Cells the Top Expression System of Best Selling Biologic Drugs”
George B. Rathmann, who was the first chief executive of Amgen and helped build it into the world’s largest biotechnology company, died on Sunday at his home in Palo Alto, Calif. He was 84.
In hundreds of documented cases that undermine a broad swath of research, cancer samples that were supposed to be one type of tumor have turned out to be another, through either careless laboratory handling, mislabeling or other mistakes.
If you like this story, please see our blog titled “Has Your Research Been Compromised? The Role of Cell-Line Authentication”